Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

Aim: The Sibutramine Cardiovascular OUTcomes trial showed that sibutramine produced greater mean weight loss than placebo but increased cardiovascular morbidity but not mortality. The relationship between 12‐month weight loss and subsequent cardiovascular outcomes is explored.

[1]  Arya M. Sharma,et al.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. , 2010, The New England journal of medicine.

[2]  David M Nathan,et al.  10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. , 2009, Lancet.

[3]  V. Salomaa,et al.  Explaining the obesity paradox: cardiovascular risk, weight change, and mortality during long-term follow-up in men. , 2009, European heart journal.

[4]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[5]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[6]  C. Nathan.  Epidemic Inflammation: Pondering Obesity , 2008, Molecular medicine.

[7]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[8]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[9]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[10]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[11]  T. Sørensen,et al.  Effects of intended weight loss on morbidity and mortality: possible explanations of controversial results. , 2006, Nutrition reviews.

[12]  A. Rissanen,et al.  Intention to Lose Weight, Weight Changes, and 18-y Mortality in Overweight Individuals without Co-Morbidities , 2005, PLoS medicine.

[13]  A. Astrup,et al.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial , 2000, The Lancet.

[14]  M. Thun,et al.  Intentional Weight Loss and Mortality among Overweight Individuals with Diabetes O R I G I N a L a R T I C L E , 2022 .

[15]  A. Folsom,et al.  Prospective study of intentionality of weight loss and mortality in older women: the Iowa Women's Health Study. , 1999, American journal of epidemiology.

[16]  U. Goldbourt,et al.  Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. , 1998, American journal of epidemiology.

[17]  K. Eriksson,et al.  No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise , 1998, Diabetologia.

[18]  Denis Muller,et al.  Long-Term Effects of Change in Body Weight on All-Cause Mortality: A Review , 1993, Annals of Internal Medicine.

[19]  Ralph D'Agostino,et al.  Benefits and Adverse Effects of Weight Loss: Observations from the Framingham Study , 1993, Annals of Internal Medicine.

[20]  R. Paffenbarger,et al.  Change in body weight and longevity. , 1992, JAMA.

[21]  Organization for Economic Cooperation and Development , 1964, International Organization.